Grapevine: Sun Pharma, Organon, Blackstone, Neysa, Medsource Ozone in news

By Nitesh Kumar

  • 19 Jan 2026
Premium

Sun Pharmaceutical Industries is weighing a potential acquisition of US‑based women’s health and biosimilars player......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.